Global Information
회사소개 | 문의 | 위시리스트

세계 암진단 시장 분야별 분석 : 발암 유전자, 생화학적 마커, 림포카인, 성장인자(GF), 증식 촉진 당단백질(CSF), 호르몬, 면역조직화학 염색 - 병원, 민간 실험실, POC(Point of Care)용 수요

Competing in the Global Cancer Diagnostics Market: Supplier Shares, Segment Forecasts for Major Tumor Markers, Growth Opportunities

리서치사 Venture Planning Group
발행일 상품 코드 309622
페이지 정보 영문
가격
US $ 18,500 ₩ 21,900,000 DataPack
US $ 27,500 ₩ 32,554,000 PDF by E-mail (Local License)
US $ 45,000 ₩ 53,271,000 PDF by E-mail (Global License)


세계 암진단 시장 분야별 분석 : 발암 유전자, 생화학적 마커, 림포카인, 성장인자(GF), 증식 촉진 당단백질(CSF), 호르몬, 면역조직화학 염색 - 병원, 민간 실험실, POC(Point of Care)용 수요 Competing in the Global Cancer Diagnostics Market: Supplier Shares, Segment Forecasts for Major Tumor Markers, Growth Opportunities
발행일 : 페이지 정보 : 영문

세계 주요 국가(미국, 유럽 주요 5개국, 일본) 암진단(Cancer Diagnostics) 시장의 향후 사업 기회에 대해 분석했으며, 현재 및 향후의 검사 기술 개요, 향후의 기술 개발 전망과 방향성, 세계 및 국가별·제품 부문별 시장 동향, 주요 기업 개요, 각 공급업체의 시장 기회 등에 대해 전해드립니다.

제1장 서론

제2장 세계 시장 개요

  • 시장 개요
  • 세계 시장 구조
  • 세계 시장 규모 및 성장률

제3장 주요 제품 개발 기회

  • 시약 키트 및 검사 시스템/패널
  • 진단 장비
  • 컴퓨터, 소프트웨어, 자동화
  • 보조 제품

제4장 분산형 검사 제품 설계 기준

제5장 대체적인 시장 진출 전략

제6장 잠재적인 시장 진출 장벽과 위험

제7장 세계 시장 및 기술 개요

  • 현재 및 향후의 주요 암진단 검사
    • 생화학적 종양마커
    • 발암 유전자
    • 폴리펩티드 성장인자
    • 이소성 호르몬
    • 증식 촉진 당단백질
    • 림포카인
    • 면역조직화학 염색
    • 신규 종양 마커
  • 진단 장비 분석과 시장 요구
  • 현재 및 향후 기술
  • 개별 검사(Personal Testing)

제8장 프랑스 시장

  • 개요
  • 사업 환경
  • 시장 구조
  • 시장 동향, 동향, 규모, 성장률
    • 시장 규모 예측 : 검사 항목 및 시장 부문별
    • 매출액 예측 : 검사 항목 및 시장 부문별
    • 주요 공급업체의 매출액 및 시장 점유율

제9장 독일 시장

제10장 이탈리아 시장

제11장 일본 시장

제12장 스페인 시장

제13장 영국 시장

제14장 미국 시장

제15장 기업 개요

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Epigenomics
  • Enterix
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio /Innogenetics
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio Inc.
  • Targeted Diagnostics & Therapeutics
  • Thermo Fisher/Life Technologies
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

제16장 부록 : 암진단 기술과 활용 방법을 개발하고 있는 주요 대학 및 연구기관

도표

LSH 14.08.18

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

This new LeadingMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

The new report contains 1,200 pages, 450 tables, and provides test volume and sales forecasts for major tumor markers, as well as supplier sales and shares by test, market segment and country. Available by country and section.

Highlights

- Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years
- Examines trends in the U.S., Europe and Japan
- Reviews current and emerging tumor markers
- Analyzes applications of emerging diagnostic technologies
- Forecasts sales of major tumor markers by country and market segment
- Profiles leading market players and potential entrants
- Suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.  During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field.  Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.  The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Market Segmentation Analysis

- Sales and market shares of major suppliers, by individual tumor marker
and country.

- Five-year test volume and sales forecasts for major
tumor markers by country and market segment,
including:

- Hospitals
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Cancer Clinics
- Ambulatory Care Centers

- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers
by country.

- Cancer statistics, etiology and recent developments in the
U.S., Japan and five major European countries.

Current and Emerging Products

- Review of over 200 current and emerging tumor markers,
including:

- Biochemical Markers
- Oncogenes
- Growth Factors
- Hormones
- Colony Stimulating Factors
- Lymphokines
- Immunohistochemical Stains, and others.

- Analysis of major immunoassay analyzers used for
tumor marker testing, including their operating characteristics,
features and selling prices.

Technology Review

- Assessment of monoclonal antibodies, immunoassays, DNA
probes, biochips/microarrays, chromosome analysis, IT,
artificial intelligence, flow cytometry, biosensors, and their
potential applications for tumor marker testing.

- Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of over 500 companies, universities and
research centers developing new tumor markers and detection technologies.

Competitive Assessments

- Extensive strategic assessments of  major suppliers
and start-up firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Worldwide Market Overview

- Estimated universe of laboratories performing tumor marker testing
by country.

- Five-year test volume and sales projections by country.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially
significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on interviews with clinical pathologists, laboratory directors,
executives from leading diagnostic companies and start-up firms
developing innovative products, university scientists, as well as
experts from industry associations, venture capital firms and the
investment banking community in the U.S., five major European
countries and Japan.

The market projections are also based on questionnaire
responses received from hospitals, commercial/private laboratories,
physician offices/group practices, cancer clinics and ambulatory
care centers in seven countries.

In addition to primary sources of information, a comprehensive
review of the most recent technical and business publications, manufacturer
product literature, patents, trade association surveys, government
studies, marketing and technical meeting presentations,
industry analyst reports, and LeadingMarketResearch.com's proprietary data files was conducted.

Contains 1,200 pages and 450 tables

Table of Contents(PARTIAL)*

I. Introduction

II. Worldwide Market Overview

  • A. Market Overview
  • B. Worldwide Market Structure
  • C. Worldwide Market Size and Growth

III. Major Product Development Opportunities

  • A. Reagent Kits and Test Systems/Panels
  • B. Instrumentation
  • C. Computers, Software and Automation
  • D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Worldwide Market and Technology Overview

  • A. Major Current and Emerging Cancer Diagnostic Tests
    • 1. Biochemical Tumor Markers
    • 2. Oncogenes
    • 3. Polypeptide Growth Factors
    • 4. Ectopic Hormones
    • 5. Colony Stimulating Factors
    • 6. Lymphokines
    • 7. Immunohistochemical Stains
    • 8. Emerging Tumor Markers
  • B. Instrumentation Review and Market Needs
  • C. Current and Emerging Technologies
  • D. Personal Testing

VIII. France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

IX. Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

X. Italy

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XI. Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XII. Spain

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XIII. U.K.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XIV. U.S.A.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

XV. Competitive Profiles

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Epigenomics
  • Enterix
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Thermo Fisher/Life Technologies
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

XVI. Appendix: Major Universities and Research

  • Centers Developing Cancer Diagnostic Technologies and Applications

List of Tables

  • Cancer Diagnostic Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
  • Executive Summary Table: France, Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
  • France, Estimated Cancer Death Rates
  • France, Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • France, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • France, Commercial/Private Laboratories Performing Cancer Diagnostic Test by Annual Test Volume
  • France, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
  • France, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
  • France, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
  • France, Commercial/Private Laboratories Marker Test Volume Forecasts
  • France, Total Cancer Diagnostic Sales Major Cancer Diagnostic Forecasts by Market Segment
  • France, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
  • France, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • France, Commercial/Private Laboratories Cancer Diagnostic Market Forecasts by Test
  • France, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market
  • France, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
  • France, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
  • France, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Progesterone Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
  • France, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecasts by Market Segment
  • France, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Thymidine Kinase Test Volume And Diagnostics Sales Forecasts by Market Segment
  • France, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • France, Total Cancer Diagnostics Sales By Major Suppliers
  • France, AFP Testing Market Diagnostics Sales by Major Supplier
  • France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • France, CEA Testing Market Diagnostics Sales by Major Supplier
  • France, NSE Testing Market Diagnostics Sales by Major Supplier
  • France, PAP Testing Market Diagnostics Sales by Major Supplier
  • France, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Germany, Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
  • Germany, Estimated Cancer Death Rates
  • Germany, Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • Germany, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • Germany, Commercial/Private Laboratories Performing Cancer Diagnostic Tests by Annual Test Volume
  • Germany, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
  • Germany, All Market Segments, Major Cancer Diagnostic Test Volume Forecasts by Test
  • Germany, Hospital Laboratories, Major Cancer Diagnostic Test Volume Forecasts by Test
  • Germany, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • Germany, Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecasts
  • Germany, Total Cancer Diagnostic Sales Forecasts by Market Segment
  • Germany, All Market Segments Major Tumor Marker Sales Forecasts by Test
  • Germany, Hospital Laboratories, Major Tumor Marker Sales Forecasts by Test
  • Germany, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Germany, Physician Offices/Group Practices Major Cancer Diagnostic Sales Forecasts by Test
  • Germany, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, CA-19 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Calcitonin Test Volume And Diagnostic Sales Forecasts by Market Segment
  • Germany, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Germany, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, HCG, Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Germany, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
  • Germany, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Germany, Total Cancer Diagnostics Sales By Major Supplier
  • Germany, AFP Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CEA Testing Market Diagnostics Sales by Major Supplier
  • Germany, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Italy, Total Cancer Diagnostic Testing Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Estimated Cancer Death Rates
  • Italy, Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • Italy, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • Italy, Commercial/Private Laboratories Performing Cancer Diagnostics Tests By Annual Test Volume
  • Italy, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
  • Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
  • Italy, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • Italy, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • Italy, Total Cancer Diagnostic Test Market Forecasts by Market Segment
  • Italy, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
  • Italy, Hospital Laboratories Major Cancer Diagnostic Forecasts by Test
  • Italy, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Italy, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, CA-19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Italy, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Italy, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
  • Italy, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, S-100 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
  • Italy, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Italy, Total Cancer Diagnostics Sales by Major Suppliers
  • Italy, AFP Testing Market Diagnostics Sales by Major Supplier
  • Italy, CEA Testing Market Diagnostics Sales by Major Supplier
  • Italy, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Japan, Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
  • Japan, Estimated Cancer Death Rates
  • Japan, Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • Japan, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • Japan, Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
  • Japan, Total Cancer Diagnostic Testing Volume Forecasts by Market Segment
  • Japan, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
  • Japan, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
  • Japan, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • Japan, Total Cancer Diagnostic Sales Forecasts by Market Segment
  • Japan, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
  • Japan, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Japan, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Japan, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Japan, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, TPA, Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Japan, Total Cancer Diagnostics Sales by Major Suppliers
  • Japan, AFP Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
  • Japan, PAP Testing Market Diagnostics Sales by Major Supplier
  • Japan, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Spain, Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
  • Spain, Estimated Cancer Death Rates
  • Spain, Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • Spain, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • Spain, Commercial/Private Laboratories Performing Cancer Diagnostics Tests By Annual Test Volume
  • Spain, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
  • Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecasts
  • Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
  • Spain, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • Spain, Total Cancer Diagnostic Sales Forecasts by Market Segment
  • Spain, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
  • Spain, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Spain, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • Spain, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, CA 15-3 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts By Market Segment
  • Spain, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, S-100 Protein Test Volume And Diagnostics Sales Forecasts by Market Segment
  • Spain, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • Spain, Total Cancer Diagnostics Sales By Major Suppliers
  • Spain, AFP Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CEA Testing Market Diagnostics Sales by Major Supplier
  • Spain, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: U.K., Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
  • U.K., Estimated Cancer Death Rates
  • U.K., Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • U.K., Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • U.K., Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
  • U.K., Total Cancer Diagnostic Testing Volume Forecasts by Market Segment
  • U.K., All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
  • U.K., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts By Test
  • U.K., Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • U.K., Total Cancer Diagnostic Sales Forecasts by Market Segment
  • U.K., All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
  • U.K., Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • U.K., Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • U.K., ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
  • U.K., Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.K., Total Cancer Diagnostics Sales and Market Shares Forecasts
  • U.K., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.K., PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: U.S., Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
  • U.S., Estimated New Cancer Cases and Deaths
  • U.S., Estimated Cancer Death Rates
  • U.S., Laboratories Performing Cancer Diagnostic Tests by Market Segment
  • U.S., Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
  • U.S., Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
  • U.S., Physician Office Laboratories Performing Cancer Diagnostic Tests By Practice Size
  • U.S., Total Cancer Diagnostic Test Volume Forecasts by Market Segment
  • U.S., All Market Segments Major Cancer Diagnostic Test Volume Forecasts
  • U.S., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
  • U.S., Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
  • U.S., Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecasts
  • U.S., Cancer Clinics Major Cancer Diagnostic Test Volume Forecasts by Test
  • U.S., Total Cancer Diagnostic Sales Forecasts by Market Segment
  • U.S., All Market Segment Major Cancer Diagnostic Sales Forecasts by Test
  • U.S., Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • U.S., Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
  • U.S., Physician Offices/Group Practices Major Cancer Diagnostic Sales Forecasts by Test
  • U.S., Cancer Clinics Major Tumor Marker Sales Forecasts by Test
  • U.S., ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., CEA Test Volume and Diagnostics Sales by Market Segment
  • U.S., Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Colon-specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
  • U.S., Cytokeratins Test Volume And Diagnostics Sales Forecasts by Market Segment
  • U.S., Estrogen Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
  • U.S., Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Interferons Test Volume And Diagnostics Sales Forecasts by Market Segment
  • U.S., Interleukins Test Volume And Diagnostics Sales Forecasts by Market Segment
  • U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Occult Blood Test Volume And Diagnostics Sales Forecasts by Market Segment
  • U.S., Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
  • U.S., Total Cancer Diagnostics Sales By Major Supplier
  • U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
  • U.S., AFP Testing Market Diagnostics Sales by Major Supplier
  • U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
  • U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • U.S., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
  • U.S., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
  • U.S., HCG Testing Market Diagnostics Sales by Major Supplier
  • U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
  • U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
  • U.S., PAP Testing Market Diagnostics Sales by Major Supplier
  • U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
  • U.S., PSA Testing Market Diagnostics Sales by Major Supplier

*[Complete Table of Contents available upon request]

Back to Top
전화 문의
F A Q